Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 566-573

  Goedert, Sigrid ^a   Germann, Tieno ^a   Hoehn, Petra ^a   Koelsch, Stephan ^a   Palm, Norbert ^a   Rüde, Erwin ^a   Schmitt, Edgar ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; L SELECTIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OKT 3; OKT 4; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; INTERFERON PRODUCTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD4; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DRUG SYNERGISM; FEMALE; GROWTH INHIBITORS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, MUTANT STRAINS; TH1 CELLS;

EID: 0030014517     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. A. Wall, W. Havran, G. Otten, M. R. Loken, M. Pierres, J. Kappler, and F. W. Fitch 1983. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74:29.
2. Wilde, D. B., P. Marrack, J. Kappler, D. P. Dialynas, and F. W. Fitch. 1983. Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J. Immunol 131:2178.
3. Cammarota, G., A. Scheirle, B. Takacs, D. M. Doran, R. Knorr, W. Bannwarth, J. Guardiola, and F. Sinigaglia. 1992. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature 356:799.
4. Doyle, C., and J. L. Strominger. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256.
5. Clayton, L. K., M. Sieh, D. A. Pious, and E. L. Reinherz. 1989. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp 120 binding. Nature 339:548.
6. Marrack, P., R. Endres, R. Shimonkevitz, A. Zlotnik, D. Dialynas, F. Fitch, and J. Kappler. 1983. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J. Exp. Med. 158:1077.
7. Eichmann, K., J. I. Jonsson, I. Falk, and F. Emmrich. 1987. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eur. J. Immunol. 17:643.
8. Anderson, P., M. L. Blue, C. Morimoto, and S. F. Schlossman. 1987. Cross-linking of T3 (CD3) with T4 (CD4) enhances the proliferation of resting T lymphocytes. J. Immunol. 139:678.
9. Sriram, S., L. Carroll, S. Fortin, S. Cooper, and G. Ranges. 1988. In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis. J. Immunol. 141:464.
10. Cobbold, S. P., S. Qin, L. Y. Leong, G. Martin, and H. Waldmann. 1992. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol. Rev. 129:165.
11. Waldmann, H., and S. Cobbold. 1993. Monoclonal antibodies for the induction of transplantation tolerance. Curr. Opin. Immunol. 5:753.
12. Waldor, M. K., S. Sriram, R. Hardy, L. A. Herzenberg, L. Lanier, M. Lim, and L. Steinman. 1985. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 227:415.
13. Ranges, G. E., S. Sriram, and S. M. Cooper. 1985. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med. 162:1105.
14. 1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378.
15. 1 mice by treatment with monoclonal antibody to L3T4. J. Immunol. 138:3247.
16. Chen, Z., S. Cobbold, S. Metcalfe, and H. Waldmann. 1992. Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8. Eur. J. Immunol. 22:805.
17. Volk, H. D., A. Siegling, C. Platzer, J. Brock, F. Emmrich, and M. Lehmann. 1994. Tolerance induction by anti-CD4 MAb treatment in a rat kidney transplantation model. Transplant. Proc. 26:3155.
18. Hancock, W. W., M. H. Sayegh, T. Sablinski, J. P. Kut, J. W. Kupiec Weglinski, and E. L. Milford. 1992. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy. Transplantation 53:1276.
19. 2 fragments of monoclonal antibody to L3T4: suppression of autoimmunity does not depend on T helper cell depletion. J. Immunol. 142: 1470.
20. Hutchings, P. R., A. Cooke, K. Dawe, H. Waldmann, and I. M. Roitt. 1993. Active suppression induced by anti-CD4. Eur. J. Immunol. 23:965.
21. Hutchings, P., L. O'Reilly, N. M. Parish, H. Waldmann, and A. Cooke. 1992. The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to β cells in NOD mice. Eur. J. Immunol. 22:1913.
22. + T cells. Transplantation 54:483.
23. Jameson, B. A., J. M. McDonnell, J. C. Marini, and R. Korngold. 1994. A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 368:744.
24. Kupiec Weglinski, J. W., B. Wasowska, I. Papp, G. Schmidbauer, M. H. Sayegh, W. M. Baldwin, K. J. Wieder, and W. W. Hancock. 1993. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J. Immunol. 151: 5053.
25. Siegling, A., M. Lehmann, H. Riedel, C. Platzer, J. Brock, F. Emmrich, and H. D. Volk. 1994. A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 57:464.
26. Kühn, R., K. Rajewsky, and W. Müller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707.
27. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
28. Spitalny, G. L., and E. A. Havell. 1984. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J. Exp. Med. 159:1560.
29. Prat, M., G. Gribaudo, P. M. Comoglio, G. Cavallo, and S. Landolfo. 1984. Monoclonal antibodies against murine gamma interferon. Proc. Natl. Acad. Sci. USA 81:4515.
30. Bazin, H., L. M. Xhurdebise, G. Burtonboy, A. M. Lebacq, L. De Clercq, and F. Cormont. 1984. Rat monoclonal antibodies. I. Rapid purification from in vitro culture supernatants. J. Immunol. Methods 66:261.
31. Ohara, J., and W. E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333.
32. Abrams, J. S., M.-G. Roncarolo, H. Yssel, U. Andersson, G. I. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
33. Sarmiento, M., D. P. Dialynas, D. W. Laincki, K. A. Wall, M. I. Lorber, M. R. Loken, and F. W. Fitch. 1982. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol. Rev. 68:135.
34. Germain, R. N., A. Bhattacharya, M. E. Dorf, and T. A. Springer. 1982. A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions. J. Immunol. 128:1409.
35. Hume, D. A., A. P. Robinson, G. G. MacPherson, and S. Gordon. 1983. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J. Exp. Med. 158:1522.
36. Sanchez Madrid, F., P. Simon, S. Thompson, and T. A. Springer. 1983. Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J. Exp. Med. 158:586.
37. Lanier, L. L., G. A. Gutman, D. E. Lewis, S. T. Griswold, and N. L. Warner. 1982. Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridomu 1:125.
38. Gallatin, W. M., I. L. Weissman, and E. C. Butcher. 1983. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30.
39. Birkeland, M. L., J. Metlay, V. M. Sanders, R. Fernandez Botran, E. S. Vitetta, R. M. Steinman, and E. Pure. 1988. Epitopes on CD45R [T200] molecules define differentiation antigens on murine B and T lymphocytes. J. Mol. Cell Immunol. 4:71.
40. Thiele, D. L., and P. E. Lipsky. 1985. Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 82:2468.
41. Ziegler Heitbrock, H. W., A. Moller, R. P. Linke, J. G. Haas, E. P. Rieber, and G. Riethmüller. 1986. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity. Cancer Res. 46:5947.
42. Echtenacher, B., W. Falk, D. N. Mannel, and P. H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachetin for recovery from experimental peritonitis. J. Immunol. 145:3762.
43. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
44. Gajewski, T. F., J. Joyce, and F. W. Fitch. 1989. Antiproliferative effect of IFN-γ in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. J. Immunol 143:15.
45. Tanaka, T., J. Hu Li, R. A. Seder, B. F. de St. Groth, and W. E. Paul. 1993. Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Natl. Acad. Sci. USA 90:5914.
46. Wu, C. Y., C. Demeure, M. Kiniwa, M. Gately, and G. Delespesse. 1993. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J. Immunol. 151:1938.
47. + T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int. Immunol 5:1119.
48. + T cells. Eau. J. Immunol. 24:343.
49. Wu, C. Y., C. E. Demeure, M. Gately, F. Podlaski, H. Yssel, M. Kiniwa, and G. Delespesse. 1994. In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J. Immunol. 152:1141.
50. Guery, J.-C., F. Galbiati, S. Smiroldo, and L. Adorini. 1996. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient BALB/c mice. J. Exp. Med. 183:485.
51. Sad, S., and T. R. Mosmann. 1994. Single IL-2-secreting precursor CD4 T cell can develop into either ThI or Th2 cytokine secretion phenotype. J. Immunol. 153:3514.
52. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccetti, S. F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type I differentiation in murine candidiasis. J. Immunol. 153: 5167.
53. Wynn, T. A., D. Jankovic, S. Hieny, K. Zioncheck, P. Jardieu, A. W. Cheever, and A. Sher. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-g. J. Immunol. 154: 3999.
54. Germann, T., S. Guckes, M. Bongartz, H. Dlugonska, E. Schmitt, L. Kolbe, E. Kölsch, F. J. Podlaski, M. K. Gately, and E. Rüde. 1995. Administration of interleukin-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgE. Int. Immunol. 7:1649.
55. Hall, S. S. 1995. IL-12 at the crossroads [news]. Science 268:1432.
56. Field, E. H., T. M. Rouse, A. L. Fleming, I. Jamali, and J. S. Cowdery. 1992. Altered IFN-γ and IL-4 pattern lymphokine secretion in mice partially depleted of CD4 T cells by anti-CD4 monoclonal antibody. J. Immunol. 149: 1131.
57. + T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J. Exp. Med. 182:5.
58. Titus, R. G., R. Ceredig, J. C. Cerottini, and J. A. Louis. 1985. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J. Immunol 135:2108.
59. Saizawa, K., J. Rojo, and C. A. Janeway. 1987. Evidence for a physical association of CD4 and the CD3:alpha:beta T-cell receptor. Nature 328:260.
60. Rivas, A., S. Takada, J. Koide, G. Sonderstrup McDevitt, and E. G. Engleman. 1988. CD4 molecules are associated with the antigen receptor complex on activated but not resting T cells. J. Immunol. 140:2912.
61. Vignali, D. A., and J. L. Strominger. 1994. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J. Exp. Med. 179:1945.